Please login to the form below

Not currently logged in
Email:
Password:

Syntaxin

This page shows the latest Syntaxin news and features for those working in and with pharma, biotech and healthcare.

Ipsen strengthens neurology efforts with Syntaxin purchase

Ipsen strengthens neurology efforts with Syntaxin purchase

The French pharma company is set to pay up to 158m for UK life sciences firm Syntaxin, including an upfront payment of 28m. ... The acquisition of Syntaxin is a considerable addition to our neurology franchise and is fully aligned with our strategy of

Latest news

  • Oncology bias in pharma deals

    112. Syntaxin/Ipsen. Research and development collaboration. Botulinum toxins. 99. Novozymes Biopharma Sweden/Repligen Corp.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics